Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Colorcon
Baxter
McKinsey
Dow

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,124,363

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,124,363
Title: Dofetilide polymorphs
Abstract:The invention relates to the substantially pure dofetilide polymorphs P162, P162a and P143, and to processes for the preparation of, compositions containing and to the uses of, such polymorphs.
Inventor(s): Appleby; Ian Colin (Sandwich, GB), Newbury; Trevor Jack (Sandwich, GB), Nichols; Gary (Sandwich, GB)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/423,986
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,124,363
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Dosage form; Use;

Drugs Protected by US Patent 6,124,363

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,124,363

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722662Oct 27, 1997
PCT Information
PCT FiledOctober 09, 1998PCT Application Number:PCT/EP98/06641
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21829

International Family Members for US Patent 6,124,363

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 906   Start Trial
Argentina 015193   Start Trial
Austria 232199   Start Trial
Australia 2151299   Start Trial
Australia 737668   Start Trial
Bulgaria 104373   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Medtronic
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.